Cynata Partners with UWA for Stem Cell Platform Studies for Lung Fibrosis
Cynata Therapeutics Ltd., an Australian regenerative medicine company developing a therapeutic stem cell platform technology called Cymerusâ„¢, has announced the launch of a study to evaluate the platform’s efficacy in treating an animal model of pulmonary fibrosis (PF) — a condition that frequently results in pulmonary…